EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE.
作者信息
SWEENEY G D, SAUNDERS S J, DOWDLE E B, EALES L
出版信息
Br Med J. 1965 May 15;1(5445):1281-5. doi: 10.1136/bmj.1.5445.1281.
Abstract
摘要
相似文献
1
EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE.
Br Med J. 1965 May 15;1(5445):1281-5. doi: 10.1136/bmj.1.5445.1281.
2
3
EXPERIMENTAL PORPHYRIA IN RATS INDUCED BY CHLORINATED BENZENES.
Biochem Pharmacol. 1963 Dec;12:1387-97. doi: 10.1016/0006-2952(63)90208-9.
4
EXPERIMENTAL DISTURBANCE OF PORPHYRIN METABOLISM AND OF LIVER CATALASE ACTIVITY IN GUINEA PIGS AND RABBITS.
Acta Pharmacol Toxicol (Copenh). 1964;21:105-15. doi: 10.1111/j.1600-0773.1964.tb01772.x.
5
EFFECT OF GRISEOFLUVIN IN ACUTE INTERMITTENT PORPHYRIA.
JAMA. 1964 May 4;188:466-8. doi: 10.1001/jama.1964.03060310066017.
6
PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
Can Med Assoc J. 1965 Jun 26;92(26):1342-4.
7
FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET.
Metabolism. 1964 Mar;13:232-50. doi: 10.1016/0026-0495(64)90103-9.
8
FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. II. THE EFFECT OF ETHINYL ESTRADIOL.
Metabolism. 1964 Mar;13:251-8. doi: 10.1016/0026-0495(64)90104-0.
9
[ON PHARMACOGENETICS].
Dtsch Gesundheitsw. 1963 Aug 22;18:1477-82.
10
[ACTION OF NUCLEOSIDES AND ADENINE NUCLEOTIDES ON THE BIOSYNTHESIS OF PORPHYRINS].
Bull Soc Chim Biol (Paris). 1963;45:1227-46.
引用本文的文献
1
Sight-threatening progressive corneo-scleral involvement in porphyria cutanea tarda.
BMJ Case Rep. 2021 Oct 19;14(10):e245160. doi: 10.1136/bcr-2021-245160.
2
Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarials: a meta-analysis.
Br J Dermatol. 2018 Dec;179(6):1351-1357. doi: 10.1111/bjd.16741. Epub 2018 Jul 26.
3
Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda.
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1402-9. doi: 10.1016/j.cgh.2012.08.038. Epub 2012 Sep 14.
4
Cutaneous hepatic porphyria and oestrogens.
Br Med J. 1966 Feb 19;1(5485):461-3. doi: 10.1136/bmj.1.5485.461.
5
The porphyrias: a review.
J Clin Pathol. 1972 Dec;25(12):1013-33. doi: 10.1136/jcp.25.12.1013.
6
[Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)].
Arch Dermatol Res (1975). 1976 Apr 21;255(2):169-76. doi: 10.1007/BF00558525.
7
Porphyria cutanea tarda: clinical and laboratory features.
Can Med Assoc J. 1979 Apr 7;120(7):803-7.
本文引用的文献
1
The spectrophotometric determination of uroporphyrin.
Scand J Clin Lab Invest. 1950;2(3):209-16. doi: 10.3109/00365515009049872.
2
Porphyria in the Bantu and some observations on the effect of chloroquine.
Cent Afr J Med. 1961 Dec;7:450-4.
3
The prophyrins and the porphyrias.
Annu Rev Med. 1961;12:251-70. doi: 10.1146/annurev.me.12.020161.001343.
4
Fatal acute chloroquine poisoning in children.
Pediatrics. 1961 Jan;27:95-102.
5
[Unusual incident in the course of treatment of cutaneous porphyria in an adult with synthetic white antipaludides].
Dermatol Wochenschr. 1959 Apr 25;139(17):445-50.
6
Cutaneous porphyria with porphobilinogenuria; a review and report of a case treated by chelation.
AMA Arch Derm. 1958 May;77(5):559-67. doi: 10.1001/archderm.1958.01560050069012.
7
The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine.
J Biol Chem. 1956 Mar;219(1):435-46.
8
Development of porphyria during chloroquine therapy for chronic discoid lupus erythematosus.
Calif Med. 1954 Sep;81(3):235-8.
9
Paper chromatography of porphyrin pigments.
Scand J Clin Lab Invest. 1953;5(2):155-7.
Zotero 插件